Liver Center News
New Yale Inflammatory Bowel Disease Center Responds to Growing Demand for IBD Treatment and Research
Recent studies estimate that by 2035, one in 100 people in the United States will have inflammatory bowel disease (IBD), a chronic inflammation of the digestive system. In response to this growing demand for IBD care, Yale School of Medicine faculty established the new Yale Inflammatory Bowel Disease Center, which serves as a hub for research, clinical care, and medical education to improve the treatment of patients with IBD.
- November 17, 2025
A new study from Yale School of Medicine researchers found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that individuals with chronic HCV infection have a 1.8-fold increased risk of pancreatic cancer compared to those who test negative for the virus.
- November 03, 2025
Nima Fattahi, MD, an associate research scientist, works in the lab of Matthew McConnell, MD, exploring how alcohol affects liver function and immune pathways. His journey — from a small Kurdish city in Iran to the Yale Liver Center — reflects a lifelong commitment to bridging science, compassion, and community.
- October 06, 2025
Tamar Taddei, MD, professor of medicine (digestive diseases), is investigating whether statins – a common, inexpensive medication – may be used to help treat cirrhosis and slow the progression to decompensated cirrhosis. In a Q&A, Taddei discusses current understanding of how statins function and her motivations and challenges in pursuing this line of research.
- September 18, 2025
New findings suggest GLP-1 receptor agonists like Ozempic reduce alcohol metabolism and its toxic metabolites. But they may also raise blood alcohol levels.
- August 05, 2025
A new collaborative program, the Ugandan Registry of RMDs in HIV (GEMINI), aims to improve the study of HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda.
- July 29, 2025
In a new study, published in Proceedings of the National Academy of Sciences, Yale School of Medicine researchers showed that excess cholesterol stored in the liver can directly drive fibrosis in the context of metabolic disease.
- July 15, 2025Source: Health
Recent research found that BMI is not a good predictor of mortality, adding to a growing body of evidence against the health metric. Here's what to measure instead.
- July 03, 2025Source: Yale News
In a new study, Yale researchers develop a method that has the potential to cure cystic fibrosis prior to birth.
- July 01, 2025
The NIH/NIDDK P30 Liver Center grant provides for the annual submission of pilot projects ($40,000 direct costs each) from both Liver Center and non-Liver Center investigators.